MENU
+Compare
CRLBF
Stock ticker: OTC
AS OF
Aug 28 closing price
Price
$1.48
Change
+$0.06 (+4.23%)
Capitalization
529.46M

CRLBF Cresco Labs Inc. Forecast, Technical & Fundamental Analysis

Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs’ national dispensary brand and others... Show more

CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CRLBF with price predictions
Aug 28, 2025

Aroon Indicator for CRLBF shows an upward move is likely

CRLBF's Aroon Indicator triggered a bullish signal on August 25, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 113 similar instances where the Aroon Indicator showed a similar pattern. In of the 113 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 25, 2025. You may want to consider a long position or call options on CRLBF as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRLBF advanced for three days, in of 243 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRLBF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CRLBF broke above its upper Bollinger Band on August 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRLBF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.184) is normal, around the industry mean (17.318). P/E Ratio (0.000) is within average values for comparable stocks, (73.434). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.903). CRLBF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (0.756) is also within normal values, averaging (41.941).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRLBF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CRLBF is expected to report earnings to fall 26.01% to -2 cents per share on November 07

Cresco Labs Inc. CRLBF Stock Earnings Reports
Q3'25
Est.
$-0.03
Q2'25
Missed
by $0.01
Q1'25
Missed
by $0.01
Q3'24
Missed
by $0.03
Q2'24
Missed
by $0.04
The last earnings report on August 07 showed earnings per share of -3 cents, missing the estimate of -3 cents. With 1.66M shares outstanding, the current market capitalization sits at 529.46M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
400 West Erie Street
Phone
+1 312 319-8442
Employees
3200
Web
https://www.crescolabs.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRIFX4.960.02
+0.42%
Catalyst/SMH Total Return Income A
BRGNX41.27N/A
N/A
iShares Russell 1000 Large-Cap Idx Instl
SCECX13.37N/A
N/A
Steward Values Enhanced SmMidCapI
PGEKX23.26N/A
N/A
Victory Pioneer Global Equity R6
DFREX41.20-0.12
-0.29%
DFA Real Estate Securities I

CRLBF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRLBF has been closely correlated with TSNDF. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRLBF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
+4.01%
TSNDF - CRLBF
76%
Closely correlated
+0.89%
CURLF - CRLBF
76%
Closely correlated
+5.20%
TCNNF - CRLBF
75%
Closely correlated
+0.89%
JUSHF - CRLBF
74%
Closely correlated
+0.11%
VRNOF - CRLBF
73%
Closely correlated
-2.37%
More

Groups containing CRLBF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
+4.01%
Pharmaceuticals: Generic
industry (224 stocks)
10%
Poorly correlated
+0.85%